Objective:To explore the therapeutic effect of using Doxophylline combined with Hanchuanzupa granules in the treatment of patients with asthmatic bronchopneumonia.Method:72 patients with wheezing bronchopneumonia who visited the hospital were selected and randomly divided into an observation group and a control group,with 36 cases in each group,using a random number table method,,with 36 cases in each group.The control group(treated with doxorubicin under mechanical sputum drainage)and the observation group(treated with doxorubicin combined with Hanchuan Zupa granules under mechanical sputum drainage)were observed and compared in terms of clinical efficacy,lung function,and improvement of inflammatory factor levels between the groups.Result:Comparing the clinical efficacy between groups,the observation group was higher than the control group(P<0.05);After 7 days of treatment,inter group comparison showed that the observation group had higher first second forced expiratory volume(FEV1),peak expiratory flow rate(PEF),and percentage of first second forced expiratory volume to forced lung activity(FEV1/FVC)(P<0.05);the levels of inflammatory factors between groups were compared.The observation group had lower peripheral blood leukocyte count(WBC)and serum high-sensitivity C-reactive protein(hs CRP)(P<0.05).Conclusion:In patients with wheezing bronchopneumonia,the combination treatment of Doxophylline and Hanchuanzupa Granules under mechanical sputum expulsion has a better therapeutic effect,and the levels of inflammatory factors and lung function are significantly improved.